GlassScriptPhysician profile
Jackson King Lau
NPI 1295141273
$1,681.62
in general payments reported to CMS, 2019-2025
20 companies · $69.74 in 2025
The $69.74 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $413 · 2021: $145 · 2022: $224 · 2023: $448 · 2024: $43.50 · 2025: $69.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $536 · Entertainment: $25.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.83 |
| Entertainment | $25.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visionary Optics LLC | $403.19 | 2023 | |
| Sun Pharmaceutical Industries INC. | $316.89 | 2020-2025 | |
| Shire North American Group INC | $267.68 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $151.80 | 2020-2022 | |
| Coopervision INC. | $90.29 | 2020-2023 | Misight Contact Lens |
| Kala Pharmaceuticals, INC. | $83.31 | 2020-2021 | |
| Tarsus Pharmaceuticals, INC. | $46.75 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $46.26 | 2019 | |
| Novartis Pharmaceuticals Corporation | $41.59 | 2020 | |
| Eyevance Pharmaceuticals LLC | $39.62 | 2019-2020 | |
| Optos, INC. | $25.55 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $24.67 | 2022 | |
| Allergan, INC. | $22.46 | 2021 | |
| Dompe US, INC. | $22.34 | 2021 | |
| Biotissue Holdings INC. | $21.65 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $21.10 | 2022 | |
| Horizon Therapeutics Plc | $19.04 | 2023 | Tepezza |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Bausch & Lomb Americas INC. | $14.83 | 2022 | |
| Abb Con-Cise Optical Group LLC | $5.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Lau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.